SecBot SecBot
DEFA14A ·Filed Apr 9, 2026

UHS

UNIVERSAL HEALTH SERVICES INC
NEUTRAL
Impact 4/10
Horizonweeks Processed7mo ago SEC0001193125-26-148828
Proxy solicitation materials
Actionable Insight • Neutral

Investors should review the proxy statement and vote on the proposals, particularly the advisory vote on executive compensation and the ratification of auditors. The shareholder proposals on financial risk reporting and workforce diversity are non-binding but may influence future corporate governance.

DirectionNeutral
Confidencehigh
Horizonweeks

How the stock moved after the report

NEUTRAL VIEWSTOCK BELOW ENTRY AT T+60
Entry
$187.57
T+0 close · Apr 9, 2026 · via day close
Latest settled
−15.74%
T+60 · $158.05
Vs SPY
−26.24%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Apr 9 $187.57entry
  2. T+1 · 7mo ago −3.69%α −3.63% · $180.64
  3. T+5 · 7mo ago −4.79%α −7.98% · $178.58
  4. T+20 · 6mo ago −10.17%α −17.74% · $168.49
  5. T+60 · 4mo ago −15.74%α −26.24% · $158.05
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Universal Health Services Inc. (UHS) filed a DEFA14A proxy statement for its 2026 annual meeting, which includes a vote on the election of director Nina Chen-Langenmayr, advisory approval of executive compensation, ratification of auditors, and two shareholder proposals on financial risk reporting and workforce diversity. This filing follows an 8-K reporting the departure of directors and the approval of 2026 incentive bonuses, indicating a board transition.

Key Financial Metrics

Vote
director election
Meeting
2026-05-20

Key Facts

  • UHS filed a DEFA14A proxy statement for its 2026 annual meeting.
  • The meeting will vote on the election of director Nina Chen-Langenmayr, advisory approval of executive compensation, ratification of auditors, and two shareholder proposals on financial risk reporting and workforce diversity.
  • This filing follows an 8-K reporting the departure of directors and the approval of 2026 incentive bonuses, indicating a board transition.
  • The Board recommends voting FOR the nominee in Proposal 1, FOR Proposal 2, FOR Proposal 3, AGAINST Proposal 4, and AGAINST Proposal 5.

Financial Impact

The financial impact is limited to the advisory vote on executive compensation and the ratification of auditors. The shareholder proposals are non-binding and do not have a direct financial impact.

executive compensationauditor fees

Risk Factors

  • The shareholder proposals on financial risk reporting and workforce diversity may not pass, indicating potential investor concerns about corporate governance.
  • The board transition may lead to changes in corporate strategy and governance.

Market Snapshot

Exchange
NYSE
Sector
Services-General Medical & Surgical Hospitals, NEC

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
DEFA14A Filing (Primary)0001193125-26-148828
Document: 0001193125-26-148828-index-headers.html0001193125-26-148828
Document: 0001193125-26-148828-index.html0001193125-26-148828
Document: 0001193125-26-148828.txt0001193125-26-148828

Track record

12 reports on UHS

Performance horizon

1 of 4 bullish or bearish reports moved the stock their way by T+1. Best: +0.71% at T+1 after the Feb 26, 2026 report. 1 of 4 went positive at some point.

Filters
  1. Oct 27, 202620d ago 8-K Bearish 6/10 No price data
  2. Oct 27, 202620d ago Press Release Bearish 5/10 Entry $172.18 to $176.61 Now $197.80 −14.88% ▼ −2.57% −2.95% vs SPY
  3. Oct 23, 202624d ago Institutional Cluster Bullish 4/10 Entry $186.89 to $185.71 Now $197.80 +5.84% ▼ −0.63% −1.34% vs SPY
  4. Oct 19, 202628d ago SC 13G Neutral 3/10 Entry $182.29 to $185.61 Now $197.80 +8.51% ▲ +1.82% +1.49% vs SPY
  5. Oct 8, 20265w ago SC 13G Neutral 3/10 Entry $175.72 to $177.35 Now $197.80 +12.57% ▲ +0.93% +0.33% vs SPY
  6. Oct 5, 20266w ago Press Release Neutral 1/10 Entry $177.08 Now $197.80 +11.70% No price data
  7. Aug 21, 202612w ago 8-K Neutral 4/10 Entry $177.26 to $176.40 Now $197.80 +11.59% ▼ −0.49% −0.19% vs SPY
  8. Jul 27, 202616w ago Press Release Bearish 6/10 Entry $166.22 to $168.16 Now $197.80 −19.00% ▼ −1.17% −2.71% vs SPY
  9. May 21, 202625w ago 8-K Neutral 3/10 Entry $162.28 to $157.52 Now $197.80 +21.89% ▼ −2.93% −3.38% vs SPY
  10. Apr 24, 202629w ago 8-K Neutral 5/10 Entry $173.78 to $179.02 Now $197.80 +13.82% ▲ +3.02% +2.85% vs SPY
Showing 10 of 12

US Market Status

Market Closed · Opens in 8h 8m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Apr 9, 2026